The likelihood of fractures among women, but not men, with type 2 diabetes is doubled with long-term use of thiazolidinediones, according to a new meta-analysis that focused on rosiglitazone maleate and pioglitazone hydrochloride. Researchers conducted a literature review to identify randomized controlled trials (RCTs) and controlled observational studies that compared the risk of fracture among patients with type 2 diabetes who were using a thiazolidinedione with those not receiving such...
The likelihood of fractures among women, but not men, with type 2 diabetes is doubled with long-term use of thiazolidinediones, according to a new meta-analysis that focused on rosiglitazone maleate and pioglitazone hydrochloride.
Researchers conducted a literature review to identify randomized controlled trials (RCTs) and controlled observational studies that compared the risk of fracture among patients with type 2 diabetes who were using a thiazolidinedione with those not receiving such therapy.
The investigators also examined studies that compared changes in bone mineral density (BMD) in patients using thiazolidinediones versus those who were not.
The review yielded 10 RCTs representing 13,715 individuals and 2 observational studies representing 31,679 individuals.
Among the RCTs, both rosiglitazone and pioglitazone were associated with a 45% increase in the odds of fractures overall (OR, 1.45; 95% CI, 1.18-1.79; P<.001). Five of these trials in particular reported fracture risk by sex, and the results revealed a more than 2-fold increase in the odds of fracture among women (OR, 2.23; 95% CI, 1.65-3.01; P<.001), although this outcome was not observed among men (OR, 1.00; 95% CI, 0.73-1.39; P=.98).
As with the RCTs, the 2 observational studies demonstrated a significant association between thiazolidinedione exposure and fractures among women but not men.
In terms of BMD changes, the studies analyzed showed a statistically significant decline in both lumbar spine and hip BMD among women who used thiazolidinediones.
The investigators suggested that the benefits of thiazolidinediones should be balanced against their long-term effects on bone and the cardiovascular system.
"Clinicians should reconsider the use of thiazolidinediones in women with type 2 diabetes," they concluded.
The study by Loke YK, et al. was published online by the Canadian Medical Association Journal as an early release Dec. 10.
Treatment with strontium ranelate--a drug used commonly to treat osteoporosis in Europe but not approved by the Food and Drug Administration--decreases the risk of vertebral fractures in young postmenopausal women who have severe osteoporosis, data suggest.
Researchers analyzed data from a subset of participants of the Spinal Osteoporosis Therapeutic Intervention trial, an international, double-blind, randomized controlled study. The subset of participants for the current...
A recent study indicates that the overall rate of instrument breakage during orthopedic procedures is low and that the risk of patient harm is small as long as certain guidelines for removal are followed.
To determine the rates of instrument breakage during orthopedic procedures at 2 hospitals and to evaluate the potential adverse effect on patients after the breakage, researchers prospectively documented every case of instrument breakage from January 2005 to December 2006. All...
The use of platelet concentration appears to improve the graft maturation process in anterior cruciate ligament (ACL) reconstruction, and the use of a bone plug may prevent tunnel widening; however, the use of platelet concentration and bone plug together may not accelerate the healing process, according to a preliminary prospective study.
Researchers evaluated patients who were candidates for ACL reconstruction between January 2005 and December 2006. The 108 patients...
Patients with inflammatory arthritis or posttraumatic arthritis of the elbow may benefit from interposition arthroplasty with an Achilles tendon allograft, new trial data demonstrate.
The investigators evaluated 69 patients with either inflammatory or posttraumatic arthritis who underwent interposition elbow arthroplasty with an Achilles tendon allograft between 1996 and 2003. Of these, 45 met the inclusion criteria for the study. The mean age at the time of presentation was 42...